Could This Healthcare Stock Help You Build a Real Fortune Over the Next 20 Years?

Pharma stocks are showing strength. Charts predict this name could break out next

Wall Street Is Betting on Eli Lilly’s GLP-1 Portfolio — It’s Missing the $1 Trillion Opportunity

Weight-loss drug developers line up to tap lucrative market as competition heats up

Health tech companies rush to market 'GLP-1 ready' products as weight loss drug trend grows

This article from Verge's Optimizer newsletter examines how health tech companies are marketing products specifically to GLP-1 drug users (p

Meta Platforms and Dexcom Highlighted as Long-Term Growth Stock Picks

The article discusses two growth stocks for long-term investment amid market volatility. Meta Platforms faces challenges including rising in

This medtech stock is trading at a discount to peers. BTIG says it's a buy